Open AccessFactors determining acceptance of illness in patients with arterial hypertension and comorbidities
Author(s) -
Magdalena Bijak,
Agnieszka Olszanecka,
E. Palczynska,
Danuta Czarnecka,
Marek Rajzer,
Katarzyna Stolarz−Skrzypek
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.15860
Subject(s) - medicine , polypharmacy , disease , comorbidity , mental illness , psychiatry , mental health
Hypertension is one of the most common chronic diseases. The need to undergo indefinite treatment combined with the risk of complications affecting the cardiovascular system impose significant psychological and somatic burden on the patient. Arterial hypertension (AH) is rarely an isolated disease and the most commonly observed comorbidities include metabolic disorders as well as clinically apparent complications associated with polypharmacy, which increases the risk of drug‑induced adverse events.